Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
allogeneic cord blood (1 trial)
amlodipine (norvasc) (4 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
atorvastatin (lipitor) (1 trial)
bifidobacterium animalis (1 trial)
cyclophosphamide (cytoxan) (3 trials)
cyclosporine (sandimmune) (2 trials)
dexmedetomidine (precedex) (2 trials)
dulaglutide (trulicity) (1 trial)
eltrombopag (promacta) (1 trial)
enterococcus faecium (1 trial)
ethambutol (myambutol) (1 trial)
insulin glargine (toujeo) (2 trials)
insulin human (humulin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
isoniazid (nydrazid) (1 trial)
Lactobacillus acidophilus (1 trial)
levofloxacin (levaquin) (1 trial)
omega-3 fatty acids (Omacor) (1 trial)
pomalidomide (pomalyst) (1 trial)
131i-lipiodol (Lipiodol) (2 trials)
anastrozole (arimidex) (1 trial)
capecitabine (xeloda) (9 trials)
cisplatin (platinol) (8 trials)
cladribine (leustatin) (1 trial)
colchicine (colbenemid) (1 trial)
epirubicin (ellence) (3 trials)
etoposide (vepesid) (3 trials)
fluorouracil (efudex) (5 trials)
geranyl farnesyl acetate (Gefarnate) (1 trial)
Acute Coronary Syndrome (Phase 4)
Adenocarcinoma (Phase 2)
Anemia (Phase 4)
Anemia, Aplastic (Phase 4)
Anterior Wall Myocardial Infarction (Phase 2)
Anxiety Disorders (Phase 1)
Apnea (Phase 3)
Arterial Occlusive Diseases (Phase 4)
Arteriosclerosis (Phase 4)
Atherosclerosis (Phase 2)
Atrial Fibrillation (Phase 4)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiomyopathies (Phase 4)
Cardiomyopathy, Dilated (Phase 4)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Constipation (Phase 3)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronavirus Infections (Phase 4)
Delirium (Phase 4)
Depressive Disorder (Phase 1)
Depressive Disorder, Major (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Disease (Phase 1)
Disseminated Intravascular Coagulation (Phase 3)
Dwarfism, Pituitary (Phase 4)
Endocrine System Diseases (Phase 4)
Essential Hypertension (Phase 3)
Gallbladder Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 2)
Head and Neck Neoplasms (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 1)
Hip Fractures (Phase 4)
Hyperhomocysteinemia (Phase 3)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hypertension (Phase 3)
Hypertriglyceridemia (Phase 3)
Hypothyroidism (Phase 1)
Infarction (Phase 2)
Infections (Phase 4)
Inflammation (Phase 4)
Irritable Bowel Syndrome (Phase 3)
Kidney Diseases (Phase 1)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Plasma Cell (Phase 2)
Lung Neoplasms (Phase 2)
Mucopolysaccharidoses (Phase 3)
Mucopolysaccharidosis II (Phase 3)
Multiple Myeloma (Phase 4)
Myelodysplastic Syndromes (Phase 4)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 4)
Nasopharyngeal Carcinoma (Phase 3)
Nausea (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 4)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 4)
Plaque, Atherosclerotic (Phase 2)
Preleukemia (Phase 4)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 4)
Renal Insufficiency, Chronic (Phase 1)
Sarcoma (Phase 2)
Schizophrenia (Phase 1)
Sepsis (Phase 3)
Sleep Apnea Syndromes (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 4)
Thrombosis (Phase 4)
Toxemia (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Tuberculosis (Phase 4)
Tuberculosis, Pulmonary (Phase 4)
Uterine Cervical Neoplasms (Phase 3)
Vascular Diseases (Phase 4)
Vomiting (Phase 3)
